Joel Greenblatt Amgen Inc Transaction History

Gotham Asset Management, LLC

$9.41 Billion
Q3 2024

A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Amgen Inc stock. As of the latest transaction made, Gotham Asset Management, LLC holds 21,405 shares of AMGN stock, worth $6.16 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

21,405

Previous 22,140 3.32%

Holding current value

$6.16 Million

Previous $6.92 Million 0.3%

% of portfolio

0.07%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $227,394 - $247,974	-735 Reduced 3.32%	21,405 $6.9 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $437,216 - $531,331	-1,664 Reduced 6.99%	22,140 $6.92 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $4.73 Million - $5.71 Million	-17,586 Reduced 42.49%	23,804 $6.77 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $2.34 Million - $2.64 Million	9,164 Added 28.44%	41,390 $11.9 Million
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $650,702 - $807,864	-2,976 Reduced 8.45%	32,226 $8.66 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $3.62 Million - $4.28 Million	16,890 Added 92.23%	35,202 $7.82 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $732,914 - $893,299	-3,246 Reduced 15.06%	18,312 $4.43 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $772,289 - $981,285	3,372 Added 18.54%	21,558 $5.66 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $86,192 - $97,209	-384 Reduced 2.07%	18,186 $4.1 Million
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $2.02 Million - $2.24 Million	8,736 Added 88.83%	18,570 $4.52 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $1.1 Million - $1.22 Million	5,025 Added 104.49%	9,834 $2.38 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $526,236 - $602,229	2,646 Added 122.33%	4,809 $1.08 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $459,140 - $537,938	2,163 New	2,163 $460,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $1.85 Million - $2.05 Million	-7,917 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $860,123 - $1 Million	3,876 Added 95.92%	7,917 $1.97 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $899,058 - $1.07 Million	-4,155 Reduced 50.7%	4,041 $929,000
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $556,355 - $618,712	-2,371 Reduced 22.44%	8,196 $2.08 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $4.07 Million - $5 Million	-20,579 Reduced 66.07%	10,567 $2.49 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $19.4 Million - $25.8 Million	-106,659 Reduced 77.4%	31,146 $6.31 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $16.7 Million - $21.4 Million	88,088 Added 177.18%	137,805 $33.2 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $10.8 Million - $12.9 Million	-61,788 Reduced 55.41%	49,717 $9.62 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $15.3 Million - $17.9 Million	-91,812 Reduced 45.16%	111,505 $20.5 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $19.4 Million - $21.9 Million	107,258 Added 111.66%	203,317 $38.6 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $9.43 Million - $11 Million	-52,844 Reduced 35.49%	96,059 $18.7 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $1.04 Million - $1.17 Million	-5,605 Reduced 3.63%	148,903 $30.9 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $19.7 Million - $22.2 Million	-118,847 Reduced 43.48%	154,508 $28.5 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $10.1 Million - $11.8 Million	59,697 Added 27.94%	273,355 $46.6 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $4.08 Million - $4.56 Million	-24,193 Reduced 10.17%	213,658 $37.2 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $39.8 Million - $45.4 Million	237,851	237,851 $44.3 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track Joel Greenblatt's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.

Account